About us
- >
- About us >
- Information >
- Announcement
2020-03-16
The phase II trial of ENERGI-F701, the solution for female hair loss treatment has completed the data analysis.
With the advantage of showing the effectiveness earlier than current drugs, Energenesis Biomedical is now actively seeking potential partners and planning to execute phase III clinical trials in the US and globally.